Balaji Gandhi Sells 836 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 836 shares of the company’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $26.98, for a total transaction of $22,555.28. Following the sale, the chief financial officer now directly owns 147,673 shares in the company, valued at approximately $3,984,217.54. The trade was a 0.56 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Stock Performance

PHR stock opened at $27.24 on Friday. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.16. The firm’s 50-day moving average is $23.54 and its 200 day moving average is $22.81. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same period in the prior year, the firm earned ($0.58) EPS. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. On average, analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PHR. Champlain Investment Partners LLC grew its position in shares of Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after buying an additional 97,847 shares in the last quarter. Franklin Resources Inc. lifted its stake in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after acquiring an additional 42,973 shares during the period. State Street Corp increased its position in Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the period. Geode Capital Management LLC increased its position in Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after purchasing an additional 55,934 shares during the period. Finally, TimesSquare Capital Management LLC raised its holdings in shares of Phreesia by 2.3% in the 3rd quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock valued at $19,791,000 after purchasing an additional 19,395 shares in the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on PHR shares. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Friday, January 10th. JMP Securities restated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a report on Tuesday, December 10th. Robert W. Baird lowered their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Finally, Citigroup boosted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.